PIRAMAL PHARMA
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of Piramal Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.27₹ 0.55
As on Sep 12, 2025, 4:01 PM IST
Piramal Pharma Price Performance
Today's LowToday's High
₹199.80₹202.00
₹200.60
52 Weeks' Low52 Weeks' High
₹180.35₹307.85
₹200.60
Open Price
₹200.10
Prev. Close
₹200.05
Volume
94,561
Over the last 5 years, the share price of Piramal Pharma has gained 1.38% CAGR. Over the past year, the corresponding return has been -13.78%.
Piramal Pharma’s current P/E of 272.18x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Piramal Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Piramal Pharma | -0.10 | 4.37 | 0.20 | -0.64 | -11.80 | 2.32 | 1.38 |
| Sun Pharmaceutical Industries | 0.97 | -1.80 | -4.65 | -4.38 | -13.15 | 21.98 | 26.56 |
| Divi's Laboratories | 0.07 | -1.47 | -9.84 | 7.01 | 9.43 | 17.82 | 13.69 |
| Cipla | 1.32 | 0.77 | 4.54 | 7.68 | -5.15 | 13.91 | 16.87 |
| Torrent Pharmaceuticals | -0.56 | -1.60 | 9.51 | 16.40 | 3.02 | 33.17 | 20.55 |
| Dr. Reddy's Laboratories | 3.77 | 5.10 | -3.31 | 18.82 | -1.15 | 15.58 | 8.56 |
| Mankind Pharma | 1.25 | 4.79 | 8.46 | 17.37 | 3.39 | 21.96 | 12.65 |
| Zydus Lifesciences | 3.03 | 5.64 | 7.16 | 18.39 | -6.58 | 40.52 | 23.17 |
| Lupin | 5.05 | 2.70 | 2.13 | 3.75 | -9.35 | 44.90 | 16.11 |
| Abbott India | -0.30 | -5.76 | -1.46 | 4.98 | 5.15 | 19.70 | 13.47 |
| Alkem Laboratories | 1.96 | 0.93 | 12.23 | 15.67 | -14.48 | 19.30 | 13.34 |
| Aurobindo Pharma | 4.78 | 1.59 | -4.90 | -0.03 | -30.19 | 25.70 | 6.59 |
| Glenmark Pharmaceuticals | 3.46 | 4.57 | 27.25 | 51.30 | 21.25 | 75.97 | 34.52 |
| Biocon | 0.26 | 1.26 | 2.62 | 12.96 | -3.71 | 6.33 | -3.24 |
| Laurus Labs | 1.70 | 3.77 | 34.34 | 56.25 | 77.18 | 17.90 | 27.44 |
| GlaxoSmithKline Pharmaceuticals | 0.17 | 0.05 | -15.89 | 4.42 | -4.41 | 24.98 | 9.94 |
| Anthem Biosciences | 0.28 | 10.26 | 13.93 | 13.93 | 13.93 | 4.44 | 2.64 |
| Cohance Lifesciences | 5.60 | -1.14 | -2.90 | -14.86 | -19.22 | 26.94 | 21.87 |
| Ipca Laboratories | -1.62 | -3.70 | -3.91 | 1.17 | -11.01 | 14.50 | 4.09 |
| Gland Pharma | 6.68 | 3.57 | 19.57 | 29.97 | 7.58 | -5.10 | 2.10 |
Over the last one year, Piramal Pharma has declined 11.80% compared to peers like Sun Pharmaceutical Industries (-13.15%), Divi's Laboratories (9.43%), Cipla (-5.15%). From a 5 year perspective, Piramal Pharma has underperformed peers relative to Sun Pharmaceutical Industries (26.56%) and Divi's Laboratories (13.69%).
Piramal Pharma Financials
Piramal Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 199.26 | 198.8 |
| 10 | 194.21 | 196.91 |
| 20 | 192.98 | 195.51 |
| 50 | 198.41 | 197.45 |
| 100 | 202.62 | 202.23 |
| 200 | 216.84 | 204.71 |
Piramal Pharma Share Holding Pattern
In the latest quarter, Piramal Pharma saw a drop in promoter holding to 34.85%, while DII stake decreased to 14.25%, FII holding fell to 30.86%, and public shareholding moved up to 19.46% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Piramal Pharma Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| HDFC Flexi Cap Fund - Regular Plan | 8,90,00,000 | 2.17 | 1,753.57 |
| HDFC Focused 30 Fund - Regular Plan | 2,50,00,000 | 2.3 | 492.58 |
| Bandhan Small Cap Fund | 58,22,899 | 0.82 | 114.73 |
| Kotak Equity Arbitrage Fund - Regular Plan | 55,40,000 | 0.15 | 109.15 |
| Franklin India Opportunities Fund | 25,55,974 | 0.68 | 50.36 |
| HDFC Business Cycle Fund | 20,38,631 | 1.37 | 40.17 |
| Aditya Birla Sun Life Small Cap Fund | 15,79,446 | 0.62 | 31.12 |
| Tata Flexi Cap Fund | 15,00,000 | 0.87 | 29.55 |
| Kotak Manufacture in India Fund | 13,50,000 | 1.07 | 26.6 |
| Invesco India Arbitrage Fund | 12,27,500 | 0.1 | 24.19 |
Piramal Pharma Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Piramal Pharma Options
Piramal Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 02, 2025, 9:15 PM IST | Piramal Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Aug 25, 2025, 9:46 PM IST | Piramal Pharma - Sustainability Report - FY2024-25 |
| Aug 21, 2025, 10:26 PM IST | Piramal Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Aug 21, 2025, 2:37 AM IST | Piramal Pharma - Announcement under Regulation 30 (LODR)-Updates on Acquisition |
| Aug 20, 2025, 11:34 PM IST | Piramal Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
About Piramal Pharma
Piramal Pharma Ltd. is a Public Limited Listed company incorporated on 04/03/2020 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is U24297MH2020PLC338592 and registration number is 338592. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 5285.71 Cr. and Equity Capital is Rs. 1324.35 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressGround Floor, Piramal Ananta, Agastya Corporate Park, Mumbai Maharashtra 400070
- Contact
Management
- Mrs. Nandini PiramalChairperson
- Mr. Peter DeYoungExecutive Director
- Mr. Vivek ValsarajExecutive Director & CFO
- Mr. Nathalie LeitchNon Executive Director
- Mr. S RamadoraiIndependent Director
- Mr. Peter StevensonIndependent Director
- Ms. Vibha Paul RishiIndependent Director
- Mr. Jairaj PurandareIndependent Director
- Mr. Sridhar GorthiIndependent Director
FAQs on Piramal Pharma Share Price
What is the share price of Piramal Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Piramal Pharma is ₹200.60 as on Sep 12, 2025.
What kind of stock is Piramal Pharma?
The Piramal Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Piramal Pharma?
The market cap of Piramal Pharma is ₹26,664.72 Cr as on Sep 12, 2025.
What are today's High and Low prices of Piramal Pharma?
Today’s highest and lowest price of Piramal Pharma are ₹202.00 and ₹199.80.
What are the 52 Week High and 52 Week Low of Piramal Pharma?
The 52-week high/low is the highest and lowest price at which Piramal Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Piramal Pharma is ₹307.85 and 52-week low of Piramal Pharma is ₹180.35 as on Sep 12, 2025.
How has the Piramal Pharma performed historically in terms of returns?
The Piramal Pharma has shown returns of 0.27% over the past day, 5.94% for the past month, 0.33% over 3 months, -13.78% over 1 year, 2.32% across 3 years, and 1.38% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Piramal Pharma?
P/E ratio of and PB ratio of Piramal Pharma are 272.18 and 3.37 on Sep 12, 2025. While the company gives a dividend yield of 0.00 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data